We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+9.92%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$401M
AUM Growth
+$37.7M
Cap. Flow
+$3.34M
Cap. Flow %
0.83%
Top 10 Hldgs %
41.72%
Holding
79
New
Increased
41
Reduced
13
Closed
4

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$589K
2
MSFT icon
Microsoft
MSFT
+$419K
3
ABT icon
Abbott
ABT
+$389K
4
UNH icon
UnitedHealth
UNH
+$380K
5
XYL icon
Xylem
XYL
+$368K

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$1.78M
2
PYPL icon
PayPal
PYPL
+$1.05M
3
DHR icon
Danaher
DHR
+$939K
4
HON icon
Honeywell
HON
+$666K
5
CVS icon
CVS Health
CVS
+$647K

Sector Composition

Rank Sector Weight
1 Technology 30.26%
2 Healthcare 18.29%
3 Industrials 12.27%
4 Consumer Discretionary 9.33%
5 Consumer Staples 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$184B
$3.77M 0.94%
22,192
-368
-2% -$61K
XOM icon
27
ExxonMobil
XOM
$650B
$3.73M 0.93%
37,347
+2,050
+6% +$215K
HON icon
28
Honeywell
HON
$78B
$3.24M 0.81%
16,379
-3,695
-18% -$666K
CVS icon
29
CVS Health
CVS
$136B
$3.01M 0.75%
38,089
-9,084
-19% -$647K
NVS icon
30
Novartis
NVS
$297B
$2.82M 0.7%
27,960
-1,055
-4% -$102K
MDT icon
31
Medtronic
MDT
$105B
$2.75M 0.69%
33,408
-225
-0.7% -$17.1K
CHD icon
32
Church & Dwight Co
CHD
$22.8B
$2.72M 0.68%
28,800
APTV icon
33
Aptiv
APTV
$11.9B
$1.94M 0.48%
21,596
+1,390
+7% +$120K
ABBV icon
34
AbbVie
ABBV
$454B
$1.7M 0.42%
10,939
-1,258
-10% -$183K
SPTM icon
35
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.4B
$1.7M 0.42%
29,000
ABNB icon
36
Airbnb
ABNB
$81.6B
$1.54M 0.38%
11,294
+1,576
+16% +$203K
ADBE icon
37
Adobe
ADBE
$84.3B
$1.2M 0.3%
2,012
+12
+0.6% +$6.92K
HUBS icon
38
HubSpot
HUBS
$9.73B
$1.16M 0.29%
2,000
BDX icon
39
Becton Dickinson
BDX
$42.1B
$1.11M 0.28%
4,555
+515
+13% +$127K
CRWD icon
40
CrowdStrike
CRWD
$187B
$1.03M 0.26%
16,060
+60
+0.4% +$3.14K
TT icon
41
Trane Technologies
TT
$106B
$955K 0.24%
3,915
MRNA icon
42
Moderna
MRNA
$22.6B
$955K 0.24%
9,600
PBA icon
43
Pembina Pipeline
PBA
$29.8B
$899K 0.22%
26,124
+3,800
+17% +$122K
MRK icon
44
Merck
MRK
$322B
$831K 0.21%
7,625
+1,500
+24% +$156K
NVO
45
Novo Nordisk
NVO
$213B
$794K 0.2%
7,680
-450
-6% -$44.5K
INTC icon
46
Intel
INTC
$504B
$789K 0.2%
15,710
+3,000
+24% +$122K
EW icon
47
Edwards Lifesciences
EW
$48.3B
$767K 0.19%
10,053
-927
-8% -$64.5K
UNP icon
48
Union Pacific
UNP
$181B
$700K 0.17%
2,851
+1,130
+66% +$248K
BMY icon
49
Bristol-Myers Squibb
BMY
$126B
$605K 0.15%
11,800
+100
+0.9% +$5.25K
TMO icon
50
Thermo Fisher Scientific
TMO
$213B
$520K 0.13%
980

Similar funds

Brian C. Broderick's Q4 2023 Portfolio in Review

As of Q4 2023, Brian C. Broderick held 79 positions worth $401M, up 10% from $363M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Brian C. Broderick's Q4 2023 filing shows 41 increased, 13 reduced and 4 closed positions. The largest sale was Illumina, an estimated $1.78M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Brian C. Broderick added most to Johnson & Johnson in Q4 2023, an estimated $589K increase.
  • Brian C. Broderick's biggest Q4 2023 reduction was Danaher, cutting an estimated $939K.
  • Brian C. Broderick fully exited Illumina in Q4 2023, selling an estimated $1.78M.
  • Brian C. Broderick's ten largest holdings make up 42% of its $401M portfolio in Q4 2023.
  • Brian C. Broderick opened 0 new positions and closed 4 in Q4 2023.
  • Brian C. Broderick's portfolio value rose 10% quarter-over-quarter to $401M.

Based on Brian C. Broderick's 13F filing for Q4 2023, filed 14 Feb 2024.